Senn hans jorg (94 Ergebnisse)

Taschenbuch. Zustand: Gut. 394 Seiten, Das gebrauchte Taschenbuch ist gut erhalten. Sprache: Deutsch Gewicht in Gramm: 340.

Broschur. Zustand: Gut. Noch originalverschweisst, daher keine Angaben zu Auflage/Paginierung möglich, Kanten gering bestossen, /// Standort Wimregal HFT-60.155 ISBN 3251400045 WITHIN THE EU: shipping only to GERMANY and AUSTRIA due to the new EPR regulations. Sprache: Deutsch Gewicht in Gramm: 430.

Hardcover. 78 S., großOktav, gebunden, Pappe. Sehr gutes Exemplar. Wirkt wie unbenutzt. With 22 Figures and 6 Tables; H. Fleisch; J.P. Bonjour and R. Rizzoli; S. Ljunghall; R. Ziegler and S.H. Scharla; P. Burckhardt, D. Thiébaud, L. Perey, and V. von Fliedner; S. Adami and M. Mian; F.J. Cleton, A.T. van Holten-Verzantvoort, and O.L.M. Bijvoet. Sprache: Englisch (unbesetzt) 312 gr. …

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Taschenbuch. Zustand: Sehr gut. 172 Seiten informa Healthcare . ESMO - 1st. Published 2008 : Dirk Schrijvers etc. - Perfect tb D0-QJTI-E1AI Sprache: Englisch Gewicht in Gramm: 299.

Hardcover. Zustand: Fine. Leichte Verschmutzung / Farbtonveränderung.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.…

Zustand: New. pp. 602.

Zustand: New. In English.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Paperback. Zustand: Brand New. reprint edition. 112 pages. 9.60x6.60x0.30 inches. In Stock.

Paperback. Zustand: Sehr gut. 2., überarbeitete auflage. oktav paperback. sehr gutes exemplar. ungelesen; 389 seiten.

Paperback. Zustand: Brand New. reprint edition. 278 pages. 9.25x6.10x0.70 inches. In Stock.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New.

Paperback. Zustand: Brand New. 484 pages. 9.25x6.10x1.09 inches. In Stock.

Zustand: New.

Paperback. Zustand: Brand New. 528 pages. 9.25x6.10x1.19 inches. In Stock.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This RRCR-conference-volume marks 'number six' in a 20-year evolution of international conferences on the adjuvant therapy of primary breast cancer. Starting in 1978, a handful of some 80 en thusiastic breast cancer surgeons and oncologists, met in a se cluded mountain resort near st. Gallen in Eastern Switzerland, to exchange their early data of some pioneer trials on adjuvant sys temic therapy of early breast cancer, and to correlate their future research efforts to overcome the frustrating prognostic stagna tion of this dominant neoplastic disease in Western females dur ing the past decades. Repeated every 3-4 years, these St. Gallen International Conferences on Adjuvant Therapy of Primary Breast Cancer have continuously grown in numbers of partici pants and in normative, therapeutic influence by being published in major oncology journals [1-3], the last (6th) conference hav ing taken place from February 25-28, 1998 with more than 1800 attendees from over 50 countries worldwide. What is the fascination of adjuvant therapy in primary (early) breast cancer, and what has changed,during the last 3 years since March 1995, to justify another international gathering of this size, and of the world's leading experts in the field There is no question, that providing even more effective care and designing appropriate recommendations for the multitudes of patients with so-called early breast cancer or at high risk of developing the disease, remain highly important public health goals.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Hans-Jorg Senn H.-J. Senn (~) Center for Tumor Detection and Prevention, Rorschacherstr. 150, CH-9006 St. Gallen, Switzerland Clinical oncology has centered mainly on developing new strategies and a multitude of new drugs for fighting relapsing and progressive cancer during the last two decades. Furthermore, it has done this with respectable success in quite a number of neoplastic diseases such as acute leukemias and sarcomas in pediatric patients and certain types of aggressive lymphomas, as well as se lected solid tumors such as testicular cancer and choriocarcinoma in adult age. Curatively intended adjuvant chemo-and endocrine-therapies of several 'main killers' among prevalent cancer types, especially breast and colon can cer, have also become successful and health-politically meaningful therapeutic targets [1, 2]. However, the net gain in 'cure' of these (mostly pharmacologic) therapeu tic approaches has to be realistically judged as having a moderate impact on the cancer problem as a whole, and the mortality rate of the most frequent tu mor types, which are prevalent in adult life, has with very few exceptions not been substantially decreased over the past two to three decades. Increasingly, health politicians, epidemiologists, and medical journal editors are asking for alternative strategies of lowering cancer incidence and increasing survival, ventilating new and hitherto mostly neglected areas of research such as pri mary and secondary cancer prevention.…

Zustand: Used. pp. 506.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The acquired immunodeficiency syndrome (AIDS) and the AIDS related complex (ARC) are caused by the human immunodeficien cy virus (HIV-I), previously known as human T-celllymphotropic virus type III (HTLV-III) or lymphadenopathy-associated virus (LA V). It seems that additional retroviruses (HIV-II and perhaps 1 3 others) are able to cause variants of AIDS or ARC. - Patients infected wi~h the virus may (but do not necessarily) de velop a wide range of clinical symptoms that are not directly relat ed to the virus itself, but are secondary to the devastating effects of the viral infection on' the human immune system. The virus thus renders the patient susceptible to a variety of opportunistic infec tions with other viruses (such as cytomegalovirus), bacteria, fungi, and protozoa, as well as to the development of simultaneous or subsequent malignant tumors. The new topic of AIDS and cancer is a challenging and frighten ing aspect of present-day medicine and health politics. With the growing prevalence of the human immunodeficiency virus(es) and clinical correlates ranging from persistent generalized lymphaden opathy (PGL) to full-blown AIDS in our population, we will also encounter a steadily rising number of patients with both AIDS and neoplasias, such as Kaposi's sarcoma, Hodgkin's and non-Hodg kin's lymphomas, anal cancer, and a variety of additional malig 4 nant tumors. , 5 1 Gallo RC, Salahuddin SZ, Popvic M et a! (1984) Frequent detection and isolation of cytopathic retroviruses (HTL V-III) from patients with AIDS and at risk for AIDS. Science 224: 500-503.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The second international symposium on 'Supportive Care in Cancer Patients' took place March 1-3, 1990-again in St. Gallen in eastern Switzerland. It was an honor once more to welcome dozens of internationally recognized experts in the field and more than 800 participants from over 30 countries around the world: Australia, Canada, China, USSR, USA and many countries in Europe. The international nature of the grade facilitated lively and exciting contributions and critical discussions, aimed at fostering professional knowledge and skills and rethinking our personal attitudes toward cancer patients in all stages of their disease. Cancer patients need various types of tailored support, whether during active initial (curative) therapies, in phases of worrying relapsing disease, or during the demanding terminal stage of their illness. The symposium tried to bridge the strange 'gap' between 'curative' and 'palliative' cancer care: it must be our aim to be and remain 'supportive' for our patients during both curative and palliative treatment strategies! This requires extended knowledge and even more and flexible professional skills. The symposium was designed to promote improved approaches that are helpful and supportive for all our oncology patients, not just for a selected disease-or stage dependent minority.…

Zustand: Used. pp. 506.

Zustand: Wie Neu. Zustandsbeschreibung: Einband leicht bestoßen. Edited by Hans-Jörg Senn, Ursula Kapp and Florian Otto. 251 Seiten, gebunden (Recent Results iin Cancer Research; Band 181/Springer-Verlag 2009). Statt EUR 123,00. Gewicht: 578 g - Gebunden/Gebundene Ausgabe.

Zustand: New. pp. 264 Illus.

Zustand: New. In English.